Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells

2016 ◽  
Vol 258 ◽  
pp. 126-133 ◽  
Author(s):  
Eun-Yeung Gong ◽  
Yu Jin Shin ◽  
Ih-Yeon Hwang ◽  
Jeong Hee Kim ◽  
Seung-Mi Kim ◽  
...  
BMB Reports ◽  
2011 ◽  
Vol 44 (3) ◽  
pp. 211-216 ◽  
Author(s):  
Sung-Ho An ◽  
Jung-Hoon Kang ◽  
Dong-Heui Kim ◽  
Myeong-Seon Lee

2015 ◽  
Vol 10 (3) ◽  
pp. 568
Author(s):  
Xiao-Bing Li ◽  
Yun-Gang Deng ◽  
Jia-Ping Hu ◽  
Zhi Wang ◽  
Rong-Zhen Xie ◽  
...  

<p><strong>Abstract</strong></p> <p><strong> </strong></p> Resveratrol is a stilbenoid compound, and a promising potent chemopreventive bioactive agent. Here, we showed for the first time that the combined treatment with resveratrol and TRAIL drastically induced apoptosis in human colon cancer cells when compared to single treatments. Further, resveratrol markedly up-regulated TRAIL receptors, DR5 and DR4 and the results revealed that DR5 siRNA efficiently blocked apoptosis induced by the co-treatment with resveratrol and TRAIL, indicating that DR5 up-regulation by resveratrol helps to enhance TRAIL actions. In addition, the combined effect were tested on normal human cells. All the obtained results suggested that resveratrol is very useful for TRAIL-based treatments for cancer.


2001 ◽  
Vol 120 (5) ◽  
pp. A493-A493
Author(s):  
J HARDWICK ◽  
G VANDENBRINK ◽  
S VANDEVENTER ◽  
M PEPPELENBOSCH

Author(s):  
Ming‐Cheng Chen ◽  
Do Chi Nhan ◽  
Chiung‐Hung Hsu ◽  
Tso‐Fu Wang ◽  
Chi‐Cheng Li ◽  
...  

Author(s):  
Pedro Carriere ◽  
Natalia Calvo ◽  
María Belén Novoa ◽  
Fernanda Lopez-Moncada ◽  
Alexander Riquelme ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document